Pancreatic cancer and FOLFIRINOX : a new era and new questions-Reference-Cited by-同舟云学术

Pancreatic cancer and FOLFIRINOX : a new era and new questions

Published:2015-02-19 Issue:6 Volume:4 Page:853-863
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Marsh Robert De W.¹,Talamonti Mark S.²,Katz Matthew Harold³,Herman Joseph M.⁴

Affiliation:

1. Department of Medicine NorthShore University HealthSystem Evanston Illinois 60201

2. Department of Surgery NorthShore University HealthSystem Evanston Illinois 60201

3. Department of Surgical Oncology The University of Texas MD Anderson Cancer Center Houston Texas

4. Department of Radiation Oncology and Molecular Radiation Sciences Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Hospital Baltimore Maryland

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.433

Reference84 articles.

1. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

2. Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

3. The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis

4. The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis

5. Randomized phase II trial comparing FOLFIRINOX (5FU/leucovorin [LV], irinotecan [I] and oxaliplatin [O]) vs gemcitabine (G) as first‐line treatment for metastatic pancreatic adenocarcinoma (MPA). First results of the ACCORD 11 trial;Ychou M.;ASCO Meeting Abstr,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world data;Annals of Epidemiology;2023-02

2. Nanoparticle-based immunotherapy of pancreatic cancer;Frontiers in Molecular Biosciences;2022-08-29

3. Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia;Biomedicines;2021-06-23

4. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy;BMC Cancer;2021-04-09

5. Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer;Scientific Reports;2021-03-22